Table 1.
Clinical material and efficacy of the 45 patients
| Characters | NO. | CR, n (%) | PR, n (%) | SD, n(%) | PD, n (%) |
|---|---|---|---|---|---|
| Gender | |||||
| Male | 19 | 0 | 15.8(3) | 36.8(7) | 47.4(9) |
| Female | 26 | 0 | 46.1(12) | 38.5(10) | 15.4(4) |
| Age(year) | |||||
| < 70 | 35 | 0 | 34.3(12) | 37.1(13) | 28.6(10) |
| ≥70 | 10 | 0 | 30.0(3) | 40.0(4) | 30.0(3) |
| Smoking status | |||||
| Smokers | 17 | 0 | 17.6(3) | 41.2(7) | 41.2(7) |
| Non-smokers | 28 | 0 | 42.9(12) | 35.7(10) | 21.4(6) |
| Tumor histology | |||||
| Adeno. | 26 | 0 | 38.5(10) | 42.3(11) | 19.2(5) |
| BAC | 4 | 0 | 75.0(3) | 25.0(1) | 0.0(0) |
| Squamous | 10 | 0 | 10.0(1) | 30.0(3) | 60.0(6) |
| Adenosquamous | 5 | 0 | 20.0(1) | 40.0(2) | 40.0(2) |
| Stage | |||||
| IIIb | 14 | 0 | 28.6(4) | 50.0(7) | 21.4(3) |
| IV | 31 | 0 | 35.4(11) | 32.3(10) | 32.3(10) |
| Brain metastasis | 4 | 0 | 75.0(3) | 25.0(1) | 0.0(0) |
| PS value | |||||
| ≤ 2 | 32 | 0 | 37.5(12) | 37.5(12) | 25.0(8) |
| 3~4 | 13 | 0 | 23.0(3) | 38.5(5) | 38.5(5) |